Vifor Pharma (GNHAY) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free GNHAY Stock Alerts $38.39 0.00 (0.00%) (As of 01/12/2023) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineApproval of delisting of Vifor Pharma AG's registered sharesfinance.yahoo.com - October 12 at 1:53 AMCara, Vifor's Kapruvia gets approval in Switzerland to treat itch in hemodialysis patientsseekingalpha.com - August 20 at 11:12 PMVifor Fresenius' rare autoimmune disease drug Tavneos gets UK NICE backingseekingalpha.com - August 19 at 9:20 PMEuropean Commission Commences Antitrust Investigation Against Vifor Pharmanasdaq.com - June 20 at 5:01 PMEU regulators investigate Vifor Pharma over anti-competitive behaviouruk.finance.yahoo.com - June 20 at 12:00 PMVifor Pharma Faces EU Antitrust Investigationmarketwatch.com - June 20 at 12:00 PMEU antitrust regulators to probe if Vifor Pharma disparages rivalfinance.yahoo.com - June 20 at 7:00 AMUpdate on the timeline for Vifor Pharma tender offerfinance.yahoo.com - May 12 at 10:34 AM94th Vifor Pharma Group Annual General Meetingfinance.yahoo.com - April 26 at 3:04 PMAmerican Kidney Fund Announces Support from Vifor Pharma for Pruritus Education Campaignapnews.com - April 2 at 11:42 AMPublication of provisional interim result for Vifor Pharma tender offer: Participation rate of 74 percentfinance.yahoo.com - March 3 at 6:24 AMAkebia Therapeutics Announces Amendment of License Agreement with Vifor Pharma in Preparation for Potential Vadadustat Launchfinance.yahoo.com - February 22 at 5:46 PMVifor Pharma appoints two new members to the Executive Committeefinance.yahoo.com - February 2 at 1:38 AMCordenPharma Completes Acquisition of Three Manufacturing Facilities from Vifor Pharmabenzinga.com - February 1 at 5:33 AMVFMCRP receives EU approval for Tavneos® for the treatment of ANCA-associated vasculitisfinance.yahoo.com - January 19 at 8:39 AMCSL BEHRING AG PUBLISHES OFFER PROSPECTUS ON PUBLIC TENDER OFFER FOR ALL PUBLICLY HELD SHARES OF VIFOR PHARMA LTD.finance.yahoo.com - January 18 at 2:25 AMVifor Pharma and American Regent announce settlement of Injectafer ® patent litigationbusinesswire.com - December 20 at 9:06 AMVifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharmafinance.yahoo.com - December 16 at 1:42 AMCSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021benzinga.com - December 14 at 2:49 PMVifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 Blnmarketwatch.com - December 14 at 8:07 AMCSL Limited announces tender offer to acquire Vifor Pharma Ltdbusinesswire.com - December 14 at 8:07 AMCSL stalked Vifor Pharma for a decadeafr.com - December 14 at 8:07 AMCSL buys Vifor Pharma in $16.4b dealafr.com - December 14 at 1:33 AMVifor Pharma: First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell diseasefinanznachrichten.de - December 10 at 2:38 PMFirst patient enrolled in phase-IIa study of vamifeport in patients with sickle cell diseasefinance.yahoo.com - December 10 at 2:38 PMAustralia's CSL in exclusive talks for $7 billion buyout of Swiss Vifor Pharma - reportinvesting.com - December 2 at 7:10 PMVifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrologyfinance.yahoo.com - November 22 at 3:45 AMVifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AGfinance.yahoo.com - November 22 at 3:45 AMCara Therapeutics, inc (CARA) Q3 2021 Earnings Call Transcriptfinance.yahoo.com - November 8 at 11:04 PMVifor Pharma announces changes to its Executive Committeefinance.yahoo.com - October 12 at 8:48 AM Get Vifor Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GNHAY and its competitors with MarketBeat's FREE daily newsletter. Email Address Exposed: 10 CENT Crypto to Explode April 20th? (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 GNHAY Media Mentions By Week GNHAY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNHAY News Sentiment▼0.000.37▲Average Medical News Sentiment GNHAY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNHAY Articles This Week▼00▲GNHAY Articles Average Week Get Vifor Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GNHAY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TGIFF News FFNTF News ABSCF News ACRDF News ACRHF News ALEAF News LBTSF News AZFL News ERBB News AVTBF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GNHAY) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersI’m afraid WWIII is a very real possibility Porter & CompanyThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vifor Pharma AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
